Skip to main content
. 2015 Jul 24;7(9):694–699. doi: 10.14740/jocmr2237w

Figure 5.

Figure 5

Changes in HbA1c (NGSP), 2 h postprandial plasma glucose for 24 weeks after liraglutide introduction by difference in SU index (glimepiride dose in mg × number of years of administration): over 5 (n = 27) or less than 5 (n = 30). **P < 0.001, *P < 0.05 compared with the values at baseline.